An Open-Label Trial of Losartan Potassium in Participants With Eosinophilic Esophagitis (EoE)

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

May 23, 2017

Primary Completion Date

July 22, 2019

Study Completion Date

August 22, 2019

Conditions
Eosinophilic Esophagitis
Interventions
DRUG

Losartan Potassium

Losartan potassium

Trial Locations (3)

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

60208

Northwestern University, Chicago

92093

University of California, San Diego, La Jolla

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

collaborator

Office of Rare Diseases (ORD)

NIH

collaborator

National Center for Advancing Translational Sciences (NCATS)

NIH

lead

Children's Hospital Medical Center, Cincinnati

OTHER

NCT03029091 - An Open-Label Trial of Losartan Potassium in Participants With Eosinophilic Esophagitis (EoE) | Biotech Hunter | Biotech Hunter